Latest News
Check Back for the Latest News About Paragonix Technologies
Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”
Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research on a variety of organ preservation, transportation and clinical data collection topics. These include data presentations comparing the impact of
Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting
Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research on a variety of organ preservation, transportation and clinical data collection topics. These include data presentations comparing the impact of
Paragonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”
From KMTV News Now Omaha OMAHA, Neb. (KMTV) — Looking at him, you might not know Tim Hagen is one in 7.9 billion. “When they found the cancer, the surgery was July 3rd, 2014, and they cut out 18 inches of my colon,” he shared. The stage IV cancer required
University of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System
CAMBRIDGE, MASSACHUSETTS – February 8, 2022 – Paragonix Technologies announced the first successful heart transplant at the University of Virginia Medical Center using it’s SherpaPak Cardiac Transport System (CTS). The SherpaPak technology provides a safe and effective way for hearts to be transported during the transplant process. The University of
Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case
Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, MASSACHUSETTS – Feb. 2, 2021 – Paragonix Technologies announces a milestone achievement for its Paragonix LUNGguard™ System as the device safely completed a record distance for donor lung transport
Legacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs
CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to provide advanced preservation for a heart and liver from the same donor. Legacy of Hope, an Alabama-based Organ Procurement Organization,
